MIZOLLEN 10 mg, modified-release tablet 15 tablets
Active ingredients: Mizolastine
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release film-coated tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIZOLLEN 10 mg, comprimé à libération modifiée
- Pharmaceutical form
- comprimé pelliculé à libération modifiée
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium polyamide PVC-Aluminium de 15 comprimé(s)
- Marketing authorisation holder
- DESMA PHARMA
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Feb 1999
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64991179CIP73639777CIP133400936397774Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIZOLASTINEcomprimé | 10,00 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.